New public Clinical Trials database leads to increased tax & regulatory transparency – risk of supply chain disruption / recall
Pharma Business Blog
MARCH 15, 2023
Dears Please find hereinafter the latest news related to Clinical Trials in the EU with a respective indirect tax and pharma regulatory licensing impact: 1. The CTIS database is publicly available and leads to increased transparency for indirect tax & pharma regulatory licensing. • What does it mean for you?
Let's personalize your content